Search
for
Sort by
Research 91–120 of 1000+
- New and Emerging Therapies for Alopecia Areata
- Hair Loss in Lichen Planopilaris and Frontal Fibrosing Alopecia: Not Always Irreversible
- Alopecia areata: from pathophysiology to therapeutic innovation
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- New Drugs for Alopecias
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Alopecia universalis. Partial response to tofacitinib
- USE OF TOFACITINIB IN DIFFICULT TO TREAT CLINICALLY AMYOPATHIC DERMATOMYOSITIS
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Tofacitinib therapy for children with severe alopecia areata
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment
- Dermatological Drugs, Topical Agents, and Cosmetics
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Remarkable Improvement of Nail Changes in Alopecia Areata Universalis with 10 Months of Treatment with Tofacitinib: A Case Report
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
- Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Therapeutic synergy between contact dermatitis from a wig‐fixing device and tofacitinib on alopecia areata
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Efficacy of systemic minoxidil and tofacitinib combination in treatment‐resistant alopecia universalis
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial